Predict your next investment

Clover Biopharmaceuticals company logo
HEALTHCARE | Biotechnology
cloverbiopharma.com

See what CB Insights has to offer

Total Raised

$347.77M

Investors Count

10

Clover Biopharmaceuticals Funding, Clover Biopharmaceuticals Valuation & Clover Biopharmaceuticals Revenue

5 Fundings

Clover Biopharmaceuticals's latest funding round was a Series C - II for $38.07M on April 28, 2021.

Date

Round

Amount

Investors

Valuation
Valuations are submitted by companies, mined from state filings or news, provided by VentureSource, or based on a comparables valuation model.

Revenue

Sources

4/28/2021

Series C - II

$38.07M

Undisclosed Investors

$0.00B

((9.99x))

FY 1234

1

2/23/2021

Series C

$99M

$0.00B

((9.99x))

FY 1234

10

6/8/2020

Series B - II

$99M

$0.00B

((9.99x))

FY 1234

10

12/2/2019

Series B

$99M

$0.00B

((9.99x))

FY 1234

10

12/14/2017

Series A

$99M

$0.00B

((9.99x))

FY 1234

10

Date

4/28/2021

2/23/2021

6/8/2020

12/2/2019

12/14/2017

Round

Series C - II

Series C

Series B - II

Series B

Series A

Amount

$38.07M

$99M

$99M

$99M

$99M

Investors

Undisclosed Investors

Valuation

Revenue

$0.00B

((9.99x))

FY 1234

$0.00B

((9.99x))

FY 1234

$0.00B

((9.99x))

FY 1234

$0.00B

((9.99x))

FY 1234

$0.00B

((9.99x))

FY 1234

Sources

1

10

10

10

10

Clover Biopharmaceuticals Investors

10 Investors

Clover Biopharmaceuticals has 10 investors. Hillhouse Capital Management invested in Clover Biopharmaceuticals's Series C funding round.

First funding

Last Funding

Investor

Rounds

Board Seats

Type

Location

6/8/2020

2/23/2021

2
Series B - II, Series C (2021)

Asset/Investment Management

China

12/2/2019

2/23/2021

2
Series B, Series C (2021)

Tim Xiao

Private Equity

New York

2/23/2021

2/23/2021

1
Series C

Public-Private Partnership

Singapore

00/00/0000

00/00/0000

Subscribe to see more

Subscribe to see more

Subscribe to see more

Corporation

China

00/00/0000

00/00/0000

Subscribe to see more

Subscribe to see more

Subscribe to see more

Venture Capital

China

First funding

6/8/2020

12/2/2019

2/23/2021

00/00/0000

00/00/0000

Last Funding

2/23/2021

2/23/2021

2/23/2021

00/00/0000

00/00/0000

Investor

Subscribe to see more

Subscribe to see more

Rounds

2
Series B - II, Series C (2021)
2
Series B, Series C (2021)
1
Series C

Subscribe to see more

Subscribe to see more

Board Seats

Tim Xiao

Subscribe to see more

Subscribe to see more

Type

Asset/Investment Management

Private Equity

Public-Private Partnership

Corporation

Venture Capital

Location

China

New York

Singapore

China

China

CB Insights uses Cookies

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.